Myrtelle

Directions Website

Myrtelle Myrtelle Inc. When not broken down by oligodendrocytes, NAA accumulates in the brain and disrupts the normal bioenergetics, myelin production, and brain health.

is a gene therapy company focused on providing hope and progress by developing transformative treatments for neurodegenerative diseases that affect patients who have few, if any, treatment options. Our lead program is a novel investigational gene therapy treatment for Canavan disease (CD), a fatal genetic brain disorder in which mutations in the ASPA gene prevent the normal expression of Aspartoacylase, a critical enzyme produced in oligodendrocyte cells that breaks down the neurochemical N-Acetylaspartic Acid (NAA). CD patients are affected at birth but may appear normal until several months, when symptoms begin to develop. Poor head control, abnormally large head size, eye tracking difficulty, excessive irritability, severely diminished muscle tone, and delays in reaching motor milestones such as rolling, sitting, and walking are typical. As the disease progresses, seizures, spasticity, difficulties in swallowing, and overall muscle deterioration emerge, with most affected children developing life-threatening complications by ten years of age. Currently, there is no cure for CD and only palliative treatments are available. Myrtelle’s social media channels are places for community members to connect and learn about Myrtelle’s initiatives. Discussion of medical and health topics should never be construed as medical advice. Contact a healthcare professional in your area for personal medical advice. Myrtelle does not represent that the information on our social media channels is accurate, complete, reliable, useful, timely, or current and Myrtelle does not undertake an obligation to update any such information. Myrtelle does not endorse any opinions or statements expressed by others on our social media channels. Myrtelle does not expressly endorse opinions or statements expressed by individuals, businesses, or channels we may ‘follow’, ‘like’, or ‘share’. At times, Myrtelle may link to external websites. Myrtelle is not responsible for the content or policies of these websites. Content submitted to our social media channels is public and will not place Myrtelle under any obligation to you.

10/15/2026

Though Canavan disease is rare, the dedication of families, researchers, and advocates ensures affected children are no longer underserved as emerging gene therapy research opens new possibilities for brighter futures.

Learn more at www.myrtellegtx.com

By guiding gene therapy straight to the cells that rebuild brain insulation, we are transforming molecular science into ...
10/13/2026

By guiding gene therapy straight to the cells that rebuild brain insulation, we are transforming molecular science into real, meaningful moments for children and families.

Learn more at www.myrtellegtx.com

While clinical trials rely on lab values and charts, the true impact of gene therapy lives in the quiet daily milestones...
10/06/2026

While clinical trials rely on lab values and charts, the true impact of gene therapy lives in the quiet daily milestones that bring lasting progress and hope to rare disease families.

Learn more: https://bit.ly/3Tj73Zy

By reaching the specific cells responsible for myelin creation, our gene therapy aims to move past managing symptoms and...
09/29/2026

By reaching the specific cells responsible for myelin creation, our gene therapy aims to move past managing symptoms and build a true foundation for lasting hope.

Learn more at www.myrtellegtx.com

By targeting oligodendrocytes directly, our cell specific gene therapy aims to restore brain insulation and lay a true f...
09/24/2026

By targeting oligodendrocytes directly, our cell specific gene therapy aims to restore brain insulation and lay a true foundation for meaningful progress in children with Canavan disease.

Learn more at www.myrtellegtx.com

While clinical endpoints measure trial progress, the true impact of gene therapy lives in the quiet, everyday moments wh...
09/16/2026

While clinical endpoints measure trial progress, the true impact of gene therapy lives in the quiet, everyday moments when a child reaches out, communicates, and engages with the world around them.

Learn more at https://bit.ly/4dDrgzS

By targeting oligodendrocytes directly, our gene therapy restores neural pathways right where myelin production and heal...
09/01/2026

By targeting oligodendrocytes directly, our gene therapy restores neural pathways right where myelin production and healing actually begin.

Learn more at www.myrtellegtx.com

By targeting oligodendrocytes to restore myelin at the biological source, Myrtelle’s lead gene therapy candidate, MYR-10...
08/25/2026

By targeting oligodendrocytes to restore myelin at the biological source, Myrtelle’s lead gene therapy candidate, MYR-101, addresses the root cause of Canavan disease while laying the foundation for a broader platform across white matter disorders.

Read the full article at www.myrtellegtx.com

Behind every clinical milestone is a family whose strength drives us forward.By delivering gene replacement to oligodend...
08/20/2026

Behind every clinical milestone is a family whose strength drives us forward.
By delivering gene replacement to oligodendrocytes, we aim to restore myelin insulation and turn precision science into real progress.

Learn more at www.myrtellegtx.com

When a genetic mutation strips away the myelin insulation that helps a child's brain connect with the world, the silence...
07/23/2026

When a genetic mutation strips away the myelin insulation that helps a child's brain connect with the world, the silence can feel overwhelming, which is why at Myrtelle we pour our hearts into restoring that vital communication and giving families their voices back.

Read more at www.myrtellegtx.com

Address

Wakefield, MA
01880

Alerts

Be the first to know and let us send you an email when Myrtelle posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share